Handelsbanken Fonder Ab Syneos Health, Inc. Transaction History

Handelsbanken Fonder Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$34.5 - $42.19 $17,250 - $21,095	-500 Reduced 2.63%	18,509 $780,000
Q1 2023 Apr 28, 2023	BUY	$33.32 - $40.98 $413,168 - $508,151	12,400 Added 187.62%	19,009 $677,000
Q4 2022 Feb 07, 2023	SELL	$25.32 - $51.45 $215,220 - $437,325	-8,500 Reduced 56.26%	6,609 $242,000
Q2 2021 Aug 03, 2021	BUY	$76.44 - $89.57 $221,676 - $259,752	2,900 Added 23.75%	15,109 $1.35 Million
Q1 2021 Apr 29, 2021	SELL	$67.36 - $80.76 $249,232 - $298,812	-3,700 Reduced 23.26%	12,209 $926,000
Q4 2020 Feb 11, 2021	SELL	$53.08 - $69.86 $148,624 - $195,608	-2,800 Reduced 14.97%	15,909 $1.08 Million
Q2 2020 Aug 13, 2020	BUY	$34.32 - $62.43 $642,092 - $1.17 Million	18,709 New	18,709 $1.09 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.